Media

2023 marks Santa Cruz Cancer Benefit Group’s 28th Anniversary. Help us mark this milestone by aiding us is raising over $2 million for our local cancer serving non-profits.

ARTICLES

Recipient of Santa Cruz Cancer Benefit Group 2019 research grant, Rebecca M. DuBois, publishes her results. The project was called, "Understanding the molecular mechanisms of a new class of immune checkpoint inhibitor." The article is in Nature.
Rebecca said the research shows "how the variability of a region in the human genome may explain why an immune checkpoint inhibitor antibody did not succeed in clinical trials. If this information and genome sequences were known before the clinical trial, maybe the patients could have been stratified for only those with sequences for which the inhibitor would be expected to work."
Nature: Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab.
Nicholas Lorig-Roach, Nina M. Harpell & Rebecca M. DuBois
January, 2024

Seed grant from Santa Cruz Cancer Benefit Group results in $2.5 million NIH grant for UCSC biomolecular engineering professor Angela Brooks.
UC Santa Cruz Newscenter: Research on understudied lung cancer drivers may improve treatments.
March 21st, 2024

UC Santa Cruz Newscenter: Unprecedented study yields most comprehensive map of cancer genomes to date.
February 05, 2020

UC Santa Cruz Newscenter: Local group funds four UC Santa Cruz researchers.
October 5th, 2018